Document is current
Any future updates will be listed below
-
Authors
Sasse, Sarah K.
Dahlin, Amber
Sanford, Lynn
Gruca, Margaret A.
Gupta, Arnav
Gally, Fabienne https://orcid.org/0000-0003-0503-7411
Wu, Ann Chen
Iribarren, Carlos
Dowell, Robin D. https://orcid.org/0000-0001-7665-9985
Weiss, Scott T.
Gerber, Anthony N. https://orcid.org/0000-0002-5280-8218
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL109557, HL152244)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM125871)
- License Information
-
More Information
Article History
Received: 8 November 2022
Accepted: 28 February 2025
First Online: 31 March 2025
Competing interests
: A.N.G. and S.K.S. consult for and own shares in Psammiad Therapeutics; R.D.D. is a cofounder of Arpeggio Biosciences; S.T.W. receives royalties from UpToDate and is on the Scientific Board of Histolix. These external interests are not directly relevant to the research presented herein, and did not influence the presented experiments or their interpretation. All other authors declare no competing interests.
